Fubotv earnings beat by $0.10, revenue topped estimates
WESTBROOK, Maine - Synergy CHC Corp. (NASDAQ: SNYR), a consumer health care and lifestyle product provider with a market capitalization of $18.66 million, has entered into a $20 million term loan credit agreement with ACP Agency, LLC, due May 2029. The company, which according to InvestingPro analysis trades at an attractive P/E ratio of 6.47, plans to use the funds to pay down existing debt and to fuel its growth initiatives.
The $15 million term loan received at closing carries an interest rate of SOFR plus 8.5%. The loan structure includes an interest-only period through 2025, followed by quarterly principal repayments starting at $175,000 in January 2026, which will increase to $350,000 quarterly from 2027 onwards. Additionally, Synergy CHC has access to a $2.5 million delayed draw facility and a $2.5 million uncommitted term loan incremental facility. The company maintains a healthy current ratio of 1.91, indicating strong ability to meet short-term obligations.
CEO Jack Ross expressed satisfaction with the refinancing, stating it aligns with the company’s growth strategy and significantly improves its capital structure. He highlighted that the terms of the loan provide the necessary balance sheet enhancement and flexibility for the company’s next growth phase. Ross also mentioned that the delayed draw facility would enable the company to fully settle debts related to previous agreements, thereby stabilizing its financial position as it pursues strategic objectives.
Synergy CHC Corp. is known for its flagship brands, including FOCUSfactor, a brain health supplement clinically tested to improve memory, concentration, and focus, and Flat Tummy, a lifestyle and wellness brand offering products aimed at weight management for women.
This financial move is part of Synergy’s broader strategy to strengthen its market position and expand its product portfolio. With impressive gross margins of 68.56% and projected revenue growth of 35% for fiscal year 2025, the company shows promising fundamentals. For deeper insights into Synergy CHC’s financial health and growth prospects, including 12 additional ProTips and comprehensive valuation metrics, visit InvestingPro. The information reported is based on a press release statement from the company and InvestingPro data.
In other recent news, Synergy CHC Corp reported a significant 30% increase in earnings per share for Q1 2025. However, the company experienced a 13% decline in net revenue, amounting to $8.2 million. The gross margin improved to 75.4% from 72% the previous year, reflecting enhanced operational efficiency. Synergy CHC is focusing on international expansion, with plans to generate revenue from its operations in Mexico by Q3 2025 and from a UAE licensing agreement by Q4 2025. Additionally, the company is planning a full rollout of its ready-to-drink beverages with Amazon and other major retailers later this year. In a strategic move to bolster its beverage division, Synergy appointed Erik Shields as Vice President of Beverage to lead the launch of its new Focus + Energy Drinks. Shields’ extensive experience in sales leadership is expected to drive revenue growth and strategic partnerships. These developments underscore Synergy CHC’s efforts to navigate challenges and capitalize on growth opportunities in the consumer health care and lifestyle products market.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.